TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE
- 20 March 1982
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 319 (8273), 643-647
- https://doi.org/10.1016/s0140-6736(82)92201-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- WILSON'S DISEASE AN ANALYSIS OF THE CRANIAL COMPUTERIZED TOMOGRAPHIC APPEARANCES FOUND IN 60 PATIENTS AND THE CHANGES IN RESPONSE TO TREATMENT WITH CHELATING AGENTSBrain, 1981
- Acute Intravascular Hemolysis and Acute Liver Failure Associated as a First Manifestation of Wilson's DiseaseAnnals of Internal Medicine, 1977
- MANAGEMENT OF PENICILLAMINE NEPHROPATHY IN WILSON'S DISEASE: A NEW CHELATING AGENTThe Lancet, 1969
- INTERRUPTION OF THE TRYPTOPHAN‐NICOTINIC ACID PATHWAY BY PENICILLAMINE‐INDUCED PYRIDOXINE DEFICIENCY IN PATIENTS WITH WILSON'S DISEASE AND IN EXPERIMENTAL ANIMALSAnnals of the New York Academy of Sciences, 1969
- The Antipyridoxine Effect of Penicillamine in Man*JCI Insight, 1964
- Separation and Characterization of Two Coeruloplasmins from Human SerumNature, 1958